271 related articles for article (PubMed ID: 27347930)
21. Targeting IDH1-Mutated Malignancies with NRF2 Blockade.
Liu Y; Lu Y; Celiku O; Li A; Wu Q; Zhou Y; Yang C
J Natl Cancer Inst; 2019 Oct; 111(10):1033-1041. PubMed ID: 30759236
[TBL] [Abstract][Full Text] [Related]
22. Nrf2 Inhibitor, Brusatol in Combination with Trastuzumab Exerts Synergistic Antitumor Activity in HER2-Positive Cancers by Inhibiting Nrf2/HO-1 and HER2-AKT/ERK1/2 Pathways.
Yang Y; Tian Z; Guo R; Ren F
Oxid Med Cell Longev; 2020; 2020():9867595. PubMed ID: 32765809
[TBL] [Abstract][Full Text] [Related]
23. Brusatol hinders the progression of bladder cancer by Chac1/Nrf2/SLC7A11 pathway.
Yu X; He Z; Wang Z; Ke S; Wang H; Wang Q; Li S
Exp Cell Res; 2024 May; 438(2):114053. PubMed ID: 38663476
[TBL] [Abstract][Full Text] [Related]
24. Coroglaucigenin enhances the radiosensitivity of human lung cancer cells through Nrf2/ROS pathway.
Sun M; Pan D; Chen Y; Li Y; Gao K; Hu B
Oncotarget; 2017 May; 8(20):32807-32820. PubMed ID: 28415625
[TBL] [Abstract][Full Text] [Related]
25. Nrf2 inhibition affects cell cycle progression during early mouse embryo development.
Lin Y; Sui LC; Wu RH; Ma RJ; Fu HY; Xu JJ; Qiu XH; Chen L
J Reprod Dev; 2018 Feb; 64(1):49-55. PubMed ID: 29249781
[TBL] [Abstract][Full Text] [Related]
26. The toxic effects and possible mechanisms of Brusatol on mouse oocytes.
Ma R; Li H; Zhang Y; Lin Y; Qiu X; Xie M; Yao B
PLoS One; 2017; 12(5):e0177844. PubMed ID: 28542354
[TBL] [Abstract][Full Text] [Related]
27. Oxidative stress associated metabolic adaptations regulate radioresistance in human lung cancer cells.
Singh B; Patwardhan RS; Jayakumar S; Sharma D; Sandur SK
J Photochem Photobiol B; 2020 Dec; 213():112080. PubMed ID: 33232882
[TBL] [Abstract][Full Text] [Related]
28. Nrf2 is a potential therapeutic target in radioresistance in human cancer.
Zhou S; Ye W; Shao Q; Zhang M; Liang J
Crit Rev Oncol Hematol; 2013 Dec; 88(3):706-15. PubMed ID: 24126138
[TBL] [Abstract][Full Text] [Related]
29. PM2.5 induces Nrf2-mediated defense mechanisms against oxidative stress by activating PIK3/AKT signaling pathway in human lung alveolar epithelial A549 cells.
Deng X; Rui W; Zhang F; Ding W
Cell Biol Toxicol; 2013 Jun; 29(3):143-57. PubMed ID: 23525690
[TBL] [Abstract][Full Text] [Related]
30. Oxidative stress, mammospheres and Nrf2-new implication for breast cancer therapy?
Wu T; Harder BG; Wong PK; Lang JE; Zhang DD
Mol Carcinog; 2015 Nov; 54(11):1494-502. PubMed ID: 25154499
[TBL] [Abstract][Full Text] [Related]
31. Downregulation of Nrf2 promotes radiation-induced apoptosis through Nrf2 mediated Notch signaling in non-small cell lung cancer cells.
Zhao Q; Mao A; Yan J; Sun C; Di C; Zhou X; Li H; Guo R; Zhang H
Int J Oncol; 2016 Feb; 48(2):765-73. PubMed ID: 26691854
[TBL] [Abstract][Full Text] [Related]
32. Nrf2 inhibition sensitizes breast cancer stem cells to ionizing radiation via suppressing DNA repair.
Qin S; He X; Lin H; Schulte BA; Zhao M; Tew KD; Wang GY
Free Radic Biol Med; 2021 Jun; 169():238-247. PubMed ID: 33892113
[TBL] [Abstract][Full Text] [Related]
33. Brusatol attenuated proliferation and invasion induced by KRAS in differentiated thyroid cancer through inhibiting Nrf2.
Gong Z; Xue L; Vlantis AC; van Hasselt CA; Chan JYK; Fang J; Wang R; Yang Y; Li D; Zeng X; Tong MCF; Chen GG
J Endocrinol Invest; 2024 May; 47(5):1271-1280. PubMed ID: 38062319
[TBL] [Abstract][Full Text] [Related]
34. Inflammation-induced radioresistance is mediated by ROS-dependent inactivation of protein phosphatase 1 in non-small cell lung cancer cells.
Kim W; Youn H; Kang C; Youn B
Apoptosis; 2015 Sep; 20(9):1242-52. PubMed ID: 26033480
[TBL] [Abstract][Full Text] [Related]
35. NRF2/miR-140 signaling confers radioprotection to human lung fibroblasts.
Duru N; Gernapudi R; Zhang Y; Yao Y; Lo PK; Wolfson B; Zhou Q
Cancer Lett; 2015 Dec; 369(1):184-91. PubMed ID: 26300493
[TBL] [Abstract][Full Text] [Related]
36. Nrf2 promotes survival following exposure to ionizing radiation.
Sekhar KR; Freeman ML
Free Radic Biol Med; 2015 Nov; 88(Pt B):268-274. PubMed ID: 25975985
[TBL] [Abstract][Full Text] [Related]
37. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.
De Bacco F; Luraghi P; Medico E; Reato G; Girolami F; Perera T; Gabriele P; Comoglio PM; Boccaccio C
J Natl Cancer Inst; 2011 Apr; 103(8):645-61. PubMed ID: 21464397
[TBL] [Abstract][Full Text] [Related]
38. The Nrf2 inhibitor brusatol has a protective role in a rat model of oxygen-induced retinopathy of prematurity.
Liang X; Wang R
Vis Neurosci; 2021 Mar; 38():E002. PubMed ID: 33729121
[TBL] [Abstract][Full Text] [Related]
39. Role of ionizing radiation activated NRF2 in lung cancer radioresistance.
Xu Q; Zhang P; Han X; Ren H; Yu W; Hao W; Luo B; Khan MI; Chen N
Int J Biol Macromol; 2023 Jun; 241():124476. PubMed ID: 37076059
[TBL] [Abstract][Full Text] [Related]
40. The variable chemotherapeutic response of Malabaricone-A in leukemic and solid tumor cell lines depends on the degree of redox imbalance.
Manna A; De Sarkar S; De S; Bauri AK; Chattopadhyay S; Chatterjee M
Phytomedicine; 2015 Jul; 22(7-8):713-23. PubMed ID: 26141757
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
